Mice deficient in Elvovl6 showed lesser frequencies of hyperglycemia, hyperinsulinemia, and hyperleptinemia and could regulate insulin sensitivity through adjustments in their hepatic fatty acid compositions. The gene discussed is INS; the disease is hyperinsulinism.